The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of 25-OH vitamin D deficiency with worse outcome for elderly patients with aggressive B-cell lymphomas treated with CHOP plus rituximab (R): An analysis of the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
Joerg Thomas Bittenbring
No relevant relationships to disclose
Marina Achenbach
No relevant relationships to disclose
Bettina Altmann
No relevant relationships to disclose
Marita Ziepert
No relevant relationships to disclose
Joerg Reichrath
No relevant relationships to disclose
Juergen Geisel
No relevant relationships to disclose
Evi Regitz
No relevant relationships to disclose
Niels Murawski
No relevant relationships to disclose
Carsten Zwick
No relevant relationships to disclose
Gerhard Held
No relevant relationships to disclose
Michael Pfreundschuh
Consultant or Advisory Role - Roche
Research Funding - Amgen; Roche